Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia

BACKGROUND: Although most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimer's Disease, only a small proportion of affected patients receive these drugs. We aimed to study if geriatric comorbidity and polypharmacy influence the prescription of ChEIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Falk, van den Bussche, Hendrik, Wiese, Birgitt, Schön, Gerhard, Koller, Daniela, Eisele, Marion, Glaeske, Gerd, Scherer, Martin, Kaduszkiewicz, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262154/
https://www.ncbi.nlm.nih.gov/pubmed/22145796
http://dx.doi.org/10.1186/1471-244X-11-190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262154/
https://www.ncbi.nlm.nih.gov/pubmed/22145796
http://dx.doi.org/10.1186/1471-244X-11-190

Ejemplares similares